Merck KGaA, Darmstadt, Germany today announced that two of its Life Science business’ CRISPR-assisted genome-editing patents have been allowed in the United States. Technology provides more tools to fight difficult-to-treat diseases Life Science business actively licensing its CRISPR-Cas9 technology for therapeutic and other uses Committed to ethical use of genome-editing technology Merck KGaA, Darmstadt, Germany, […]
LexaGene Files Patent Application for Expanded Capabilities of Their LX Analyzer To meet higher COVID-19 testing needs in reference laboratories BEVERLY, Mass. – LexaGene Holdings, Inc., (OTCQB: LXXGF; TSX-V: LXG) (the “Company”), a biotechnology company that develops genetic analyzers for rapid pathogen detection and other molecular markers, announced today the filing of a provisional patent application […]
Merck today announced that the United States Patent and Trademark Office has granted the company’s patent for CRISPR-chrom technology. CRISPR-chrom technology improves access to genome for more efficient editing Only U.S. patent holder in the CRISPR chromatin space Company driving innovation in CRISPR gene-editing technologies Darmstadt, Germany — Merck, a leading science and technology […]
The UK has formed a genome sequencing alliance, to enable rapid, broad, large-scale sequencing analysis of samples from patients testing positive for COVID-19. The resulting data will help deliver insights into how the virus is transmitted and how it evolves. Oxford Nanopore is delighted to support participating teams across the UK in this project, including […]
After more than one week of evidence, a federal jury in Delaware found in favour of Oxford Nanopore and invalidated all four patents asserted by Pacific Biosciences (“PacBio”) in this litigation. During the trial, the jury heard evidence that PacBio had never performed nanopore sequencing, before or after they filed patents that allegedly cover nanopore […]
Menlo Park – Pacific Biosciences of California, Inc., a leading provider of high-quality sequencing of genomes, transcriptomes and epigenomes, announced that the jury verdict in the U.S. District Court for the District of Delaware was not overall favorable for Pacific Biosciences, but mixed in terms of its findings. Although the jury sided with Pacific Biosciences […]
SAN DIEGO — Illumina, Inc. (NASDAQ: ILMN) today announced that it has filed a patent infringement suit relating to BGI’s “CoolMPS” sequencing products. The complaint was filed against BGI Genomics Co., Ltd., BGI Americas Corp., MGI Tech Co., Ltd., MGI Americas, Inc. and Complete Genomics Inc. in the United States District Court for the Northern […]
DUBLIN, Ireland – ERS Genomics Limited, which was formed to provide broad access to the foundational CRISPR/Cas9 intellectual property held by Dr. Emmanuelle Charpentier, announced today that the European Patent Office (EPO) has rejected arguments filed in opposition to European patent No. EP2800811 jointly held by Dr. Charpentier, the Regents of the University of California, and […]
NEW YORK — Enzo Biochem, Inc. (NYSE:ENZ) (the “Company”) today disclosed that Harbert Discovery Fund, LP (“Harbert”) filed a lawsuit against the Company and the members of its board of directors (“Board”) in the U.S. District Court for the Southern District of New York. Enzo commented as follows: “We are disappointed but not surprised by […]
SANTA CLARA, Calif. — Agilent Technologies Inc. (NYSE: A) today announced it has reached an agreement with Twist Bioscience under which Twist has agreed to pay Agilent a sum of $22.5 million to settle Agilent’s claims against Twist, as well as current and former Twist employees Emily Leproust, Siyuan Chen, and Solange Glaize. The claims […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
